Synthesis of phosphonate and phostone analogues of ribose-1-phosphates

• Pitak Nasomjai,
• David O'Hagan and
• Alexandra M. Z. Slawin

Beilstein J. Org. Chem. 2009, 5, No. 37, doi:10.3762/bjoc.5.37

• isomerase, the next enzyme on the pathway, and in order to probe the molecular mechanism of this enzyme, these phosphonates and the phostones 10 and 11 are being used in co-crystallisation trials with each of the over-expressed enzymes (PNP and isomerase). Experimental Nuclear magnetic resonance (NMR

The development and evaluation of a continuous flow process for the lipase- mediated oxidation of alkenes

• Charlotte Wiles,
• Marcus J. Hammond and
• Paul Watts

Beilstein J. Org. Chem. 2009, 5, No. 27, doi:10.3762/bjoc.5.27

• , Fisher Scientific). In all cases, materials were used as received. Instrumentation Unless otherwise stated, nuclear magnetic resonance (NMR) spectra were obtained at room temperature as solutions in deuterated chloroform (CDCl3) using a Jeol GX400 spectrometer; in the case of known compounds, all spectra

Synthesis and redox behavior of new ferrocene- π-extended- dithiafulvalenes: An approach for anticipated organic conductors

• Abdelwareth A. O. Sarhan,
• Omar F. Mohammed and
• Taeko Izumi

Beilstein J. Org. Chem. 2009, 5, No. 6, doi:10.3762/bjoc.5.6

• . 1H NMR and 13C NMR spectra were recorded at room temperature on a Varian Nuclear Magnetic Resonance Spectrometer (500 MHz). Chemical shifts are denoted in δ units (ppm), relative to tetramethylsilane (TMS) as internal standard, J values are given in Hz. MS and FAB-MS spectra were obtained using a

Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel

• Karunananda Bombuwala,
• Thomas Kinstle,
• Vladimir Popik,
• Sonal O. Uppal,
• James B. Olesen,
• Jose Viña and
• Carol A. Heckman

Beilstein J. Org. Chem. 2006, 2, No. 13, doi:10.1186/1860-5397-2-13

• Proton Nuclear Magnetic Resonance. Supporting Information File 40: VRO showing microtubule + ends localized by antibody against EB1 in a control cell. Part of the VRO is rendered in a two-dimensional form in Figure 2. Control cells were treated with solvent vehicle only. Note that + ends of microtubules